Concomitant Inhibition of IRE1α/XBP1 Axis of UPR and PARP: A Promising Therapeutic Approach against c-Myc and Gammaherpesvirus-Driven B-Cell Lymphomas

被引:4
|
作者
Benedetti, Rossella [1 ]
Arena, Andrea [1 ]
Romeo, Maria Anele [1 ]
Gilardini Montani, Maria Saveria [1 ]
Gonnella, Roberta [1 ]
Santarelli, Roberta [1 ]
Trivedi, Pankaj [1 ]
Cirone, Mara [1 ]
机构
[1] Sapienza Univ Rome, Dept Expt Med, Viale Regina Elena 324, I-00161 Rome, Italy
关键词
Burkitt lymphoma; UPR; IRE1; alpha/XBP1; c-Myc; DDR; BRCA-1; CANCER-CELLS; EXPRESSION; MECHANISMS; RESISTANCE; LATENCY;
D O I
10.3390/ijms23169113
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
It is emerging that targeting the adaptive functions of Unfolded Protein Response (UPR) may represent a promising anti-cancer therapeutic approach. This is particularly relevant for B-cell lymphomas, characterized by a high level of constitutive stress due to high c-Myc expression. In this study, we found that IRE1 alpha/XBP1 axis inhibition exerted a stronger cytotoxic effect compared to the inhibition of the other two UPR sensors, namely PERK and ATF6, in Burkitt lymphoma (BL) cells, in correlation with c-Myc downregulation. Interestingly, such an effect was more evident in Epstein-Barr virus (EBV)-negative BL cells or those cells expressing type I latency compared to type III latency BL cells. The other interesting finding of this study was that the inhibition of IRE1 alpha/XBP1 downregulated BRCA-1 and RAD51 and potentiated the cytotoxicity of PARP inhibitor AZD2661 against BL cells and also against Primary Effusion Lymphoma (PEL), another aggressive B-cell lymphoma driven by c-Myc and associated with gammaherpesvirus infection. These results suggest that combining the inhibition of UPR sensors, particularly IRE1 alpha/XBP1 axis, and molecules involved in DDR, such as PARP, could offer a new therapeutic opportunity for treating aggressive B-cell lymphomas such as BL and PEL.
引用
收藏
页数:13
相关论文
共 1 条
  • [1] CONCOMITANT INHIBITION OF EZH1 AND EZH2 IMPAIRS GROWTH OF C-MYC DRIVEN B CELL LYMPHOMAS
    Petrocelli, V.
    Varano, G.
    Carrisi, C.
    Rahmat, M.
    Zanardi, F.
    Jin, J.
    Casola, S.
    HAEMATOLOGICA, 2014, 99 : 133 - 134